Komori
Other Disclosures4593HEALIOS K.K.Pharmaceuticals

Participation in the Jefferies Global Healthcare Conference

The company announced that its CFO is scheduled to speak at the Jefferies Global Healthcare Conference, to be held in New York on 4 June 2026, and explain the company’s business strategy and other matters. A live webcast is scheduled, followed by 60 days of archive access.

Worth reading
37Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
60
Days (webcast archive access period)
Wording
Definitive
How definitive the wording is.

Announced details

Presentation on business strategy and other matters at the Jefferies Global Healthcare Conference
Applicable field (uses covered by this announcement)

Healthcare, regenerative medicine and biotechnology (as described in the company overview)

Launch date4 June 2026 (scheduled, U.S. Eastern Time)
Relationship between the counterparty and the company
HEALIOS K.K.4593
Relationship with the Company

Participation in the conference and delivery of a presentation

CounterpartyJefferies
Location (as indicated in this announcement)

New York City, U.S. (conference venue)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

Jefferies website

Announced details
ItemDetails
Names of Products / Services CoveredPresentation on business strategy and other matters at the Jefferies Global Healthcare Conference
CounterpartyJefferies
Relationship with the CompanyParticipation in the conference and delivery of a presentation
Launch date4 June 2026 (scheduled, U.S. Eastern Time)
Applicable areaHealthcare, regenerative medicine and biotechnology (as described in the company overview)
LocationNew York City, U.S. (conference venue)
SourceJefferies website
Items this document does not state (11)
Counterparty overviewContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To inform investors of the scheduled conference presentation and how to view it.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Participation in the Jefferies Global Healthcare Conference | HEALIOS K.K. (4593) timely disclosure | Komori